• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知行为疗法对首发精神病患者大麻戒除的作用:一项为期 1 年的随机对照试验

Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.

机构信息

Centre for Biomedical Research in the Mental Health Network (CIBERSAM), 28029 Madrid, Spain.

Bioaraba Research Institute, Department of Psychiatry, Araba University Hospital, 01004 Vitoria, Spain.

出版信息

Int J Environ Res Public Health. 2022 Jun 15;19(12):7325. doi: 10.3390/ijerph19127325.

DOI:10.3390/ijerph19127325
PMID:35742573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224093/
Abstract

Despite the negative influence of cannabis use on the development and prognosis of first-episode psychosis (FEP), there is little evidence on effective specific interventions for cannabis use cessation in FEP. The aim of this study was to compare the efficacy of a specific cognitive behavioral therapy (CBT) for cannabis cessation (CBT-CC) with treatment as usual (TAU) in FEP cannabis users. In this single-blind, 1-year randomized controlled trial, 65 participants were randomly assigned to CBT-CC or TAU. The primary outcome was the reduction in cannabis use severity. The CBT-CC group had a greater decrease in cannabis use severity and positive psychotic symptoms over time, and a greater improvement in functioning at post-treatment than TAU. The treatment response was also faster in the CBT-CC group, reducing cannabis use, anxiety, positive and general psychotic symptoms, and improving functioning earlier than TAU in the follow-up. Moreover, patients who stopped and/or reduced cannabis use during the follow-up, decreased psychotic symptoms and increased awareness of disease compared to those who continued using cannabis. Early intervention based on a specific CBT for cannabis cessation, may be effective in reducing cannabis use severity, in addition to improving clinical and functional outcomes of FEP cannabis users.

摘要

尽管大麻使用会对首发精神病(FEP)的发展和预后产生负面影响,但针对 FEP 患者大麻戒除的有效特定干预措施的证据很少。本研究旨在比较针对大麻戒除的特定认知行为疗法(CBT-CC)与常规治疗(TAU)在 FEP 大麻使用者中的疗效。在这项为期 1 年的单盲随机对照试验中,65 名参与者被随机分配至 CBT-CC 组或 TAU 组。主要结局是大麻使用严重程度的降低。随着时间的推移,CBT-CC 组的大麻使用严重程度和阳性精神病症状下降更大,治疗后功能改善更大。CBT-CC 组的治疗反应也更快,在随访中比 TAU 更早地减少大麻使用、焦虑、阳性和一般精神病症状,并改善功能。此外,与继续使用大麻的患者相比,在随访期间停止和/或减少大麻使用的患者,其精神病症状减少,对疾病的认识增加。基于针对大麻戒除的特定 CBT 的早期干预,可能有助于降低大麻使用严重程度,同时改善 FEP 大麻使用者的临床和功能结局。

相似文献

1
Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.认知行为疗法对首发精神病患者大麻戒除的作用:一项为期 1 年的随机对照试验
Int J Environ Res Public Health. 2022 Jun 15;19(12):7325. doi: 10.3390/ijerph19127325.
2
A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis.多中心、随机、对照试验:一种针对首发精神病的联合临床治疗方法。
Int J Environ Res Public Health. 2021 Jul 6;18(14):7239. doi: 10.3390/ijerph18147239.
3
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.首发精神病患者大麻使用戒断的认知行为疗法项目:一项随机对照试验的研究方案
Trials. 2016 Jul 29;17:372. doi: 10.1186/s13063-016-1507-x.
4
Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trial.首发精神病患者社交焦虑的定式团体认知行为治疗:一项随机对照试验。
Psychol Med. 2023 Jun;53(8):3335-3344. doi: 10.1017/S0033291721005328. Epub 2022 Jan 11.
5
Cognitive behavior therapy in early psychosis with a focus on depression and low self-esteem: A randomized controlled trial.聚焦于抑郁和低自尊的早期精神病认知行为治疗:一项随机对照试验。
Compr Psychiatry. 2020 Feb;97:152157. doi: 10.1016/j.comppsych.2019.152157. Epub 2019 Dec 26.
6
Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.利用移动技术在早期精神病中提供认知行为疗法指导的干预措施(Actissist):一项随机对照试验的研究方案
Trials. 2015 Sep 10;16:404. doi: 10.1186/s13063-015-0943-3.
7
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.抗精神病药物与心理干预及两者联合用于首发精神病青少年(MAPS):一项多中心、三臂、随机对照试验性及可行性研究
Lancet Psychiatry. 2020 Sep;7(9):788-800. doi: 10.1016/S2215-0366(20)30248-0. Epub 2020 Jul 7.
8
Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.针对精神病的认知行为疗法:一项卫生技术评估。
Ont Health Technol Assess Ser. 2018 Oct 24;18(5):1-141. eCollection 2018.
9
Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.成人大麻戒断的心理和社会心理干预:系统评价简短报告
Health Technol Assess. 2015 Jul;19(56):1-130. doi: 10.3310/hta19560.
10
Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.大麻使用与首发精神病性症状增加及社会心理功能较差有关:来自英国国家EDEN研究的报告。
Schizophr Bull. 2016 May;42(3):619-25. doi: 10.1093/schbul/sbv154. Epub 2015 Nov 4.

引用本文的文献

1
Telehealth tDCS to reduce cannabis use: A pilot RCT in multiple sclerosis as a framework for generalized use.远程医疗经颅直流电刺激减少大麻使用:一项针对多发性硬化症的随机对照试验试点,作为广泛应用的框架。
Drug Alcohol Depend. 2025 Jul 1;272:112706. doi: 10.1016/j.drugalcdep.2025.112706. Epub 2025 May 15.
2
Cannabis use disorder: from neurobiology to treatment.大麻使用障碍:从神经生物学到治疗。
J Clin Invest. 2024 Oct 15;134(20):e172887. doi: 10.1172/JCI172887.
3
Using Task-fMRI to Explore the Relationship Between Lifetime Cannabis Use and Cognitive Control in Individuals With First-Episode Schizophrenia.

本文引用的文献

1
Early intervention comes late.早期干预姗姗来迟。
Eur Neuropsychopharmacol. 2022 Jun;59:1-3. doi: 10.1016/j.euroneuro.2022.02.010. Epub 2022 Mar 19.
2
Precision psychotherapy.精准心理治疗
Eur Neuropsychopharmacol. 2022 Feb;55:20-21. doi: 10.1016/j.euroneuro.2021.10.771. Epub 2021 Nov 9.
3
Cannabis use and psychosis susceptibility: A call to action.大麻使用与精神病易感性:行动呼吁。
使用任务功能磁共振成像技术探索首次发作精神分裂症患者终生大麻使用与认知控制之间的关系。
Schizophr Bull Open. 2024 Jul 24;5(1):sgae016. doi: 10.1093/schizbullopen/sgae016. eCollection 2024 Jan.
4
Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis.认知行为疗法添加到首发和近期起病精神分裂症的标准治疗中。
Cochrane Database Syst Rev. 2024 Mar 12;3(3):CD015331. doi: 10.1002/14651858.CD015331.pub2.
5
Use of the Therapy App Prescinde for Increasing Adherence to Smoking Cessation Treatment.使用Prescinde治疗应用程序提高戒烟治疗的依从性。
Healthcare (Basel). 2023 Dec 8;11(24):3121. doi: 10.3390/healthcare11243121.
Eur Neuropsychopharmacol. 2022 Jan;54:70-71. doi: 10.1016/j.euroneuro.2021.09.004. Epub 2021 Sep 24.
4
A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis.多中心、随机、对照试验:一种针对首发精神病的联合临床治疗方法。
Int J Environ Res Public Health. 2021 Jul 6;18(14):7239. doi: 10.3390/ijerph18147239.
5
The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years.家庭环境和精神疾病家族史对首发精神病患者基线时及 2 年后社会心理功能的影响。
Eur Neuropsychopharmacol. 2021 Aug;49:54-68. doi: 10.1016/j.euroneuro.2021.03.015. Epub 2021 Apr 12.
6
The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds.首发精神病患者应用功能评估短量表(FAST):心理测量学特性和严重程度阈值。
Eur Neuropsychopharmacol. 2021 Jun;47:98-111. doi: 10.1016/j.euroneuro.2021.02.007. Epub 2021 Feb 28.
7
Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies.阿戈美拉汀 25-50mg 治疗广泛性焦虑障碍焦虑症状和功能损害的疗效:三项安慰剂对照研究的荟萃分析。
Adv Ther. 2021 Mar;38(3):1567-1583. doi: 10.1007/s12325-020-01583-9. Epub 2021 Feb 4.
8
The impact of sex and cannabis on clinical features in first-admitted patients with psychosis.性与大麻对首发精神病患者临床特征的影响。
Eur Neuropsychopharmacol. 2020 Jul;36:235-243. doi: 10.1016/j.euroneuro.2020.03.003. Epub 2020 Apr 12.
9
Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review.调节大麻使用与精神病风险之间关联的因素:一项系统综述。
Brain Sci. 2020 Feb 12;10(2):97. doi: 10.3390/brainsci10020097.
10
Cannabis use and psychosis: a review of reviews.大麻使用与精神病:综述研究。
Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28.